The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Publications

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 39 results:
Author [ Title(Desc)] Type Year
Filters: Author is Terpos, Evangelos  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
A
Gavriatopoulou, M., Kastritis E., Ntanasis-Stathopoulos I., Fotiou D., Roussou M., Migkou M., et al. (2018).  The addition of IMiDs for patients with daratumumab-refractory multiple myeloma can overcome refractoriness to both agents.. Blood. 131(4), 464-467.
Polyzos, S. A., Kountouras J., Papatheodorou A., Katsiki E., Patsiaoura K., Zafeiriadou E., et al. (2013).  Adipocytokines and cytokeratin-18 in patients with nonalcoholic fatty liver disease: Introduction of CHA index.. Ann Hepatol. 12(5), 749-57.
B
Dimopoulos, M. A., Roussou M., Gavriatopoulou M., Psimenou E., Eleutherakis-Papaiakovou E., Migkou M., et al. (2016).  Bortezomib-based triplets are associated with a high probability of dialysis independence and rapid renal recovery in newly diagnosed myeloma patients with severe renal failure or those requiring dialysis.. Am J Hematol. 91(5), 499-502.
C
Dimopoulos, M. A., Roussou M., Gavriatopoulou M., Psimenou E., Ziogas D., Eleutherakis-Papaiakovou E., et al. (2017).  Cardiac and renal complications of carfilzomib in patients with multiple myeloma.. Blood Adv. 1(7), 449-454.
Makri, E., Orfanidou M., Makri E. S., Goulas A., Terpos E., & Polyzos S. A. (2024).  Circulating Ferritin in Patients with Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.. J Clin Exp Hepatol. 14(3), 101353.
Anastasilakis, A. D., Polyzos S. A., Makras P., Rauner M., Sonnleitner L., Hawa G., et al. (2019).  Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass.. J Musculoskelet Neuronal Interact. 19(3), 253-257.
Polyzos, S. A., Anastasilakis A. D., Kountouras J., Makras P., Papatheodorou A., Kokkoris P., et al. (2016).  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.. J Bone Miner Metab. 34(4), 447-56.
Anastasilakis, A. D., Polyzos S. A., Makras P., Gkiomisi A., Sakellariou G., Savvidis M., et al. (2015).  Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.. Expert Opin Ther Targets. 19(3), 299-306.
Polyzos, S. A., & Terpos E. (2016).  Clinical vertebral fractures following denosumab discontinuation.. Endocrine. 54(1), 271-272.
Ziogas, D. C., Terpos E., Gavriatopoulou M., Migkou M., Fotiou D., Roussou M., et al. (2018).  Coexistence of leishmaniasis and multiple myeloma in the era of monoclonal antibody (anti-CD38 or anti-SLAMF7) containing triplets: one shared story of two exceptional cases.. Leuk Lymphoma. 59(4), 983-987.
D
Bagratuni, T., Ntanasis-Stathopoulos I., Gavriatopoulou M., Mavrianou-Koutsoukou N., Liacos C., Patseas D., et al. (2018).  Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies.. Leukemia.
Kastritis, E., Gavriatopoulou M., Kyrtsonis M-C., Roussou M., Hadjiharissi E., Symeonidis A., et al. (2015).  Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study.. Blood. 126(11), 1392-4.
Polyzos, S. A., Anastasilakis A. D., Litsas I., Sapranidis M., Efstathiadou Z., Kita M., et al. (2010).  Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1.. J Clin Densitom. 13(2), 190-6.
E
Anastasilakis, A. D., Polyzos S. A., Avramidis A., Toulis K. A., Papatheodorou A., & Terpos E. (2010).  The effect of teriparatide on serum Dickkopf-1 levels in postmenopausal women with established osteoporosis.. Clin Endocrinol (Oxf). 72(6), 752-7.
Kastritis, E., Kostopoulos I. V., Terpos E., Paiva B., Fotiou D., Gavriatopoulou M., et al. (2018).  Evaluation of minimal residual disease using next-generation flow cytometry in patients with AL amyloidosis.. Blood Cancer J. 8(5), 46.
Kastritis, E., Terpos E., Roussou M., Gavriatopoulou M., Migkou M., Eleutherakis-Papaiakovou E., et al. (2017).  Evaluation of the Revised International Staging System in an independent cohort of unselected patients with multiple myeloma.. Haematologica. 102(3), 593-599.
G
Kastritis, E., Papassotiriou I., Merlini G., Milani P., Terpos E., Basset M., et al. (2018).  Growth differentiation factor-15 is a new biomarker for survival and renal outcomes in light chain amyloidosis.. Blood. 131(14), 1568-1575.
H
Polyzos, S. A., Kountouras J., Papatheodorou A., Patsiaoura K., Katsiki E., Zafeiriadou E., et al. (2013).  Helicobacter pylori infection in patients with nonalcoholic fatty liver disease.. Metabolism. 62(1), 121-6.
Ziogas, D. C., Kastritis E., Terpos E., Roussou M., Migkou M., Gavriatopoulou M., et al. (2017).  Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens.. Leuk Lymphoma. 58(8), 1832-1839.
L
Katodritou, E., Terpos E., Kastritis E., Delimpasis S., Symeonidis A. S., Repousis P., et al. (2015).  Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experience.. Ann Hematol. 94(12), 2033-42.
Anastasilakis, A. D., Polyzos S. A., Tsoli M., Papatheodorou A., Kokkoris P., Kaltsas G., et al. (2017).  Low periostin levels in adult patients with Langerhans cell histiocytosis are independently associated with the disease activity.. Metabolism. 71, 198-201.
M
Polyzos, S. A., & Terpos E. (2018).  Mild leukopenia following denosumab treatment in a woman with postmenopausal osteoporosis.. Endocrine. 62(2), 487-489.
N
Polyzos, S. A., Kountouras J., Anastasilakis A. D., Makras P., Hawa G., Sonnleitner L., et al. (2018).  Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.. Hormones (Athens). 17(4), 573-579.
Polyzos, S. A., Anastasilakis A. D., Anagnostis P., Kita M., Arsos G., Moralidis E., et al. (2012).  Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid.. Endokrynol Pol. 63(4), 312-5.
Polyzos, S. A., Kountouras J., Slavakis A., Zafeiriadou E., Patsiaoura K., Katsiki E., et al. (2013).  A novel noninvasive index for nonalcoholic steatohepatitis: a pilot study.. Biomarkers. 18(7), 607-13.

Pages

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.